Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial

@article{Jamieson2012MaternalAI,
  title={Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial},
  author={Denise J. Jamieson and Charles S Chasela and Michael G. Hudgens and Caroline C. King and Athena P. Kourtis and Dumbani Kayira and Mina C Hosseinipour and Deborah D Kamwendo and Sascha R. Ellington and Jeffrey B Wiener and Susan A. Fiscus and Gerald L Tegha and Innocent A Mofolo and Dorothy S Sichali and Linda S. Adair and Rodney J Knight and Francis E A Martinson and Zebrone K Kacheche and Alice Soko and Irving F. Hoffman and Charles Michael van der Horst},
  journal={The Lancet},
  year={2012},
  volume={379},
  pages={2449-2458}
}
BACKGROUND In resource-limited settings where no safe alternative to breastfeeding exists, WHO recommends that antiretroviral prophylaxis be given to either HIV-infected mothers or infants throughout breastfeeding. We assessed the effect of 28 weeks of maternal or infant antiretroviral prophylaxis on postnatal HIV infection at 48 weeks. METHODS The Breastfeeding, Antiretrovirals, and Nutrition (BAN) Study was undertaken in Lilongwe, Malawi, between April 21, 2004, and Jan 28, 2010. 2369 HIV… CONTINUE READING

From This Paper

Figures and tables from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothers.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2010

Similar Papers

Loading similar papers…